Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meister

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunotoxicology|March 9, 2010
High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic featuresE M Weiss, S Meister, C Janko, et al.
Journal of Public Health Management and Practice : JPHMP|August 15, 2002
Building community capacity in public health: the role of action-oriented partnershipsM A Veazie, N I Teufel-Shone, G S Silverman, et al.
Scientific Reports|June 26, 2019
HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinomaKara S Meister, Neal R Godse, Nayel I Khan, et al.
Preventing Chronic Disease|September 19, 2007
From program to policy: expanding the role of community coalitionsAnne Hill, Jill Guernsey De Zapien, Lisa K Staten, et al.
Research Square|February 24, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.
Nature Communications|September 5, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.
Scientific Reports|December 19, 2023
Characterization and prognostic impact of ACTBL2-positive tumor-infiltrating leukocytes in epithelial ovarian cancerN E Topalov, D Mayr, C Kuhn, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
DNA-guided CRISPR/Cas12 for RNA targetingCarlos Orosco, Santosh R Rananaware, Boyu Huang, et al.
Nature Biotechnology|May 15, 2026
DNA-guided CRISPR-Cas12 for cellular RNA targetingCarlos Orosco, Boyu Huang, Santosh R Rananaware, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunotoxicology|March 9, 2010
High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic featuresE M Weiss, S Meister, C Janko, et al.
Journal of Public Health Management and Practice : JPHMP|August 15, 2002
Building community capacity in public health: the role of action-oriented partnershipsM A Veazie, N I Teufel-Shone, G S Silverman, et al.
Scientific Reports|June 26, 2019
HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinomaKara S Meister, Neal R Godse, Nayel I Khan, et al.
Preventing Chronic Disease|September 19, 2007
From program to policy: expanding the role of community coalitionsAnne Hill, Jill Guernsey De Zapien, Lisa K Staten, et al.
Research Square|February 24, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.
Nature Communications|September 5, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.
Scientific Reports|December 19, 2023
Characterization and prognostic impact of ACTBL2-positive tumor-infiltrating leukocytes in epithelial ovarian cancerN E Topalov, D Mayr, C Kuhn, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
DNA-guided CRISPR/Cas12 for RNA targetingCarlos Orosco, Santosh R Rananaware, Boyu Huang, et al.
Nature Biotechnology|May 15, 2026
DNA-guided CRISPR-Cas12 for cellular RNA targetingCarlos Orosco, Boyu Huang, Santosh R Rananaware, et al.
Pageof 6